Welcome to our dedicated page for Procter & Gamble SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Procter & Gamble Company filings document material-event reporting for an Ohio-incorporated consumer products issuer with PG common stock listed on the New York Stock Exchange. The company’s recent 8-K records identify its registered common stock and a broad schedule of exchange-listed notes.
Those disclosures cover capital-structure reference points, including U.S. dollar, euro and British pound notes with maturities spanning short- and long-dated issues. The filings also provide recurring public-company identifiers, exchange listings and formal reporting details tied to P&G’s securities.
Procter & Gamble Form 144 notice reports a proposed sale of 714 shares of common stock, with an aggregate market value of $110,602.17, to be sold on the NYSE on or about 08/19/2025. The shares were acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company and were paid for on 08/18/2025. The filing lists total shares outstanding of 2,342,371,488, indicating the sale is immaterial relative to the companys total float. The filer certifies they are unaware of any undisclosed material adverse information and provides standard Rule 144 representations regarding trading plans and compliance.
Form 144 notice for Procter & Gamble Company (PG). The filer notifies intent to sell 11,198 shares of Common Stock through Morgan Stanley Smith Barney LLC on the NYSE with an approximate sale date of 08/19/2025. The aggregate market value of the proposed sale is reported as $1,734,626.19 and the issuer's shares outstanding are shown as 2,342,371,488. The securities were acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company; the filer lists acquiring 18,834 shares and indicates payment on 08/18/2025. No sales in the past three months are reported. The notice includes the standard representation about lack of undisclosed material adverse information.
Alexandra Keith, Chief Executive Officer – Beauty at The Procter & Gamble Company, has announced her intention to retire effective February 20, 2026, after more than 36 years with the company. Upon retirement she will enter the company’s standard Written Separation Agreement, which does not provide any cash severance and allows her to retain the remainder of a special equity award scheduled to vest in August 2026.
Per the report, all other equity awards will be retained or pro-rated as set out in the applicable Award Agreement. The disclosure does not include details about a successor or additional transition arrangements.
Procter & Gamble (PG) – Form 4 filed 08/07/2025. Chief Operating Officer Shailesh Jejurikar disclosed only acquisitions, no sales of company equity.
- Direct common stock: 9,982.2858 shares after the transactions.
- Indirect common stock: 3,301.9815 shares via retirement plan; 19,757 shares in the Sankhya S Jejurikar Revocable Trust; 17,849 shares in the Shailesh Jejurikar Trust.
- Derivative activity: Four separate grants of Restricted Stock Units (RSUs) and preferred-stock equivalents were reported: 31.0041 RSUs (02/18/25), 33.4003 RSUs (05/15/25), 0.3416 Series A preferred shares convertible into common stock (07/14/25), and 725 RSUs as a retirement award (08/07/25).
- All entries carry transaction code “A” (acquisition), and each grant was made at $0 cost as part of dividend-equivalent, retirement, or compensation programs.
- Total derivative holdings following the filing: 494.5685 + 527.9688 + 1,001.0622 + 725 ≈ 2,749 units/shares, split between direct and retirement-plan accounts.
No dispositions, option exercises, or open-market trades were reported; the filing merely updates ownership records and corrects small prior misstatements related to dividend-equivalent RSUs.
Filing: Form 4 filed 08/07/2025 by Marc S. Pritchard, Chief Brand Officer, for Procter & Gamble Co. (PG).
Non-derivative: Table I reports Common Stock entries including 173,134.4375 (marked D), 47,439.3762 (marked I — by Retirement Plan Trustees), 602 (I — by wife) and three entries of 107.032 (I — daughters ACP, CEP, NJP).
Derivative: Table II shows RSU-related acquisitions: 02/18/2025 — 207.3581 RSUs; 05/15/2025 — 223.3836 RSUs; 07/14/2025 — Series A Preferred 0.6323 (underlying 12,512.679 common stock) held by Retirement Plan Trustees; and 08/07/2025 — 1,253 RSUs. Explanations state RSUs include dividend equivalents and retirement-plan awards; Series A conversion/exercise price is the higher of $6.82 (post-split) or market price. The form is signed 08/07/2025 by attorney-in-fact Wednesday Shipp.
Procter & Gamble (PG) Form 4: Chief Legal Officer & Secretary Susan Street Whaley reported routine equity awards and updated share ownership as of 08/07/2025.
- Direct common-stock holding: 19,670.1407 shares.
- Indirect holding: 6,477.4515 shares via retirement plan trustee.
- New derivative grants: 772 Restricted Stock Units (RSUs) credited as a retirement award on 08/07/2025; no cash outlay.
- Dividend-equivalent RSUs: 6.1043 units (02/18/25) and 6.5759 units (05/15/25) added; both deliverable upon retirement.
- Series A preferred stock adjustment: 0.6322 units credited 07/14/25, convertible to common on distribution.
No shares were sold; all transactions are automatic, price-free allocations tied to dividend equivalents or retirement benefits. The officer now controls roughly 26,148 direct/indirect shares plus 1,833 RSU-equivalent derivatives—immaterial versus PG’s large float, indicating a neutral governance signal rather than a market-moving event.
On 08/07/2025 Procter & Gamble (PG) officer Sundar G. Raman, CEO of Fabric & Home Care, filed a Form 4 detailing only equity acquisitions and no dispositions.
- Direct common-stock ownership rises to 29,920.5607 shares.
- Indirect holdings via the retirement plan now total 8,366.3969 shares.
- New awards include 1,055 RSUs (retirement award) plus 41.6846 RSU dividend equivalents granted earlier in 2025, all recorded with code “A” at $0 price, reflecting plan-based grants rather than open-market buys.
- Derivative position: 1,417.28 RSUs directly and 2,061.8592 Series A preferred shares indirectly convertible to common.
The filing increases Raman’s beneficial ownership by roughly 1,097 new share equivalents (<~US$165k at $150/sh), a modest rise relative to PG’s market cap but directionally positive since no shares were sold.
Form 4 highlights (filed 7 Aug 2025): Procter & Gamble’s Chief Research, Development & Innovation Officer, Moses V. J. Aguilar, disclosed routine equity accruals delivered through company compensation plans—no open-market trading occurred.
- New awards: 780 Restricted Stock Units (RSUs) granted on 08/07/2025; 12.5783 dividend-equivalent RSUs credited 05/15/2025; 0.6323 shares of Series A preferred stock credited 07/14/2025 via retirement plan.
- Cost: All issuances at $0, classified as code “A” (award) with “V” modifier, indicating non-discretionary, benefit-plan transactions.
- Post-transaction holdings: Direct ownership—25,351.0828 common shares plus 877.6365 RSUs; Indirect—6,750.7456 common shares and 1,782.2509 preferred shares held by plan trustees.
- RSUs and preferred shares convert to PG common stock upon retirement or plan distribution per plan rules.
No sales, dispositions, or market purchases were reported; the filing does not materially alter insider ownership percentage or signal a directional view on PG’s share price.